erucyl phosphate | 213738-87-5

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 有机磷酸及其衍生物
• 英文名称: erucyl phosphate
• 英文别名: Erucyl-phosphoric acid；[(Z)-docos-13-enyl] dihydrogen phosphate
• CAS: 213738-87-5
• 化学式: C₂₂H₄₅O₄P
• 分子量: 404.571
• InChiKey: HLAZSMAGWSARDR-KTKRTIGZSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  8.5
• 重原子数：
  27
• 可旋转键数：
  21
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.91
• 拓扑面积：
  66.8
• 氢给体数：
  2
• 氢受体数：
  4

反应信息

• 作为产物：
  描述：

  13-二十二烯醇 在 N-甲基咪唑 、 N,O-双三甲硅基乙酰胺 、 三甲基溴硅烷 作用下， 以 二氯甲烷 为溶剂， 反应 20.5h， 生成 erucyl phosphate
  参考文献：
  名称：

  Compositions containing lysophosphatidic acids which inhibit apoptosis and uses thereof

  摘要：

  该发明提供了抗凋亡组合物溶磷脂酸及其制备和使用方法。这种组合物还可以包含增强LPA作用的剂，包括蛋白质、脂质膜结构和聚合物，如聚乙二醇。该组合物还可以额外含有其他药用有效剂，如药物、抗生素、伤口愈合剂和抗氧化剂。

  公开号：

  US06949528B1

文献信息

• [EN] COMPOSITIONS CONTAINING LYSOPHOSPHOTIDIC ACIDS WHICH INHIBIT APOPTOSIS AND USES THEREOF<br/>[FR] COMPOSITIONS CONTENANT DES ACIDES LYSOPHOSPHOTIDIQUES INHIBANT L'APOPTOSE, ET LEURS UTILISATIONS
  申请人：LXR BIOTECHNOLOGY INC.

  公开号：WO1998041213A1

  公开（公告）日：1998-09-24

  (EN) The present invention provides therapeutic compositions containing lysophosphatidic acids, methods for making the compositions, and methods of use thereof.(FR) La présente invention concerne des compositions thérapeutiques contenant des acides lysophosphotidiques, des procédés permettant de fabriquer les compositions, et des procédés d'utilisation de celles-ci.

  该发明提供了含有溶血磷脂酸的治疗组合物、制备该组合物的方法以及使用该组合物的方法。
• Compositions containing lysophosphotidic acids which inhibit apoptosis and uses thereof
  申请人：Bathurst C. Ian

  公开号：US20060063738A1

  公开（公告）日：2006-03-23

  The present invention provides therapeutic compositions containing lysophosphatidic acids, methods for making the compositions, and methods of use thereof.

  本发明提供了含有溶血磷脂酸的治疗组合物，制备该组合物的方法以及使用该组合物的方法。
• COMPOSITIONS CONTAINING LYSOPHOSPHATIDIC ACIDS WHICH INHIBIT APOPTOSIS AND USES THEREOF
  申请人：Goddard G. John

  公开号：US20080076736A1

  公开（公告）日：2008-03-27

  The invention provides anti-apoptotic compositions containing lysophosphatidic acids and methods for making and using the compositions. Such compositions may also contain LPA potentiating agents, including proteins, lipid membrane structures and polymers such as polyethylene glycols. The compositions can additionally contain other pharmaceutically effective agents such as drugs, antibiotics, wound healing agents and antioxidants.

  本发明提供了含有溶血磷脂酸的抗凋亡组合物及其制备和使用方法。这样的组合物还可以含有LPA增效剂，包括蛋白质、脂质膜结构和聚合物，如聚乙二醇。该组合物还可以另外含有其他药效物质，如药物、抗生素、伤口愈合剂和抗氧化剂。
• Flame retardant and flame retardant resin composition
  申请人：KYOWA CHEMICAL INDUSTRY CO., LTD.

  公开号：EP0356139A1

  公开（公告）日：1990-02-28

  A process for producing a flame retardant is disclosed, which comprises contacting magnesium hydroxide with a surface treating agent which is a dialcohol amine salt of an alcohol phosphate ester having the following formula (1): wherein R is a Cio-C30, linear or branched, alkyl or alkylene group, R' is a C1-C6, linear or branched, alkyl group and n is 1 or 2, or an alcohol phosphate ester, or alkali metal salt thereof, having the following formula (2): wherein R and n are as defined above in connection with formula (1) and M is an alkali metal or hydrogen, provided that, when n = 1, each of the two M's is independently an alkali metal or hydrogen. A substance suitable for use as a flame retardant is also disclosed, comprising dehydrated Mg(OH)2 having bound to its surface the group wherein R is as defined above.

  本发明公开了一种生产阻燃剂的工艺，包括将氢氧化镁与一种表面处理剂接触，该表面处理剂是具有下式（1）的醇磷酸酯的二醇胺盐： 其中 R 为 Cio-C30 直链或支链烷基或亚烷基，R'为 C1-C6 直链或支链烷基，n 为 1 或 2，或具有下式（2）的醇磷酸酯或其碱金属盐： 其中 R 和 n 如上文有关式（1）的定义，M 为碱金属或氢，但当 n = 1 时，两个 M 中的每一个都独立地为碱金属或氢。 还公开了一种适合用作阻燃剂的物质，包括脱水 Mg（OH）2，其表面结合有基团 其中 R 如上定义。
• Crystalline polyolefin composition
  申请人：Chisso Corporation

  公开号：EP0416321A1

  公开（公告）日：1991-03-13

  A crystalline polyolefin composition which provides molded articles having improved stiffness characteristics is disclosed, comprising 100 parts by weight of a crystalline polyolefin, (A) from 0.001 to 1 part by weight of a fluorophosphite compound represented by formula (I): wherein R represents an alkylidene group having from 1 to 4 carbon atoms or a sulfur atom; Ar1 and Ar2, which may be the same or different, each represents an alkylarylene group or a cycloalkylarylene group; and n represents 0 or 1, and (B) from 0.001 to 1 part by weight of at least one compound selected from the group consisting of (1) an aliphatic monocarboxylic acid salt with lithium or sodium, (2) a dithiocarbamic acid salt with lithium, sodium or potassium, (3) a 2-mercaptobenzothiazole salt with lithium, sodium or potassium, (4) a 2-mercaptobenzimidazole salt with lithium, sodium or potassium and (5) a benzotriazole salt with lithium, sodium or potassium. A crystalline polyolefin composition which provides molded articles having improved stiffness charateristics is also disclosed, comprising 100 parts by weight of a crystalline polyolefin, (A) from 0.001 to 1 part by weight of a fluorophosphite compound represented by formula (I) shown above, (B ) from 0.001 to 1 part by weight of at least one compound selected from the group consisting of (1) an aliphatic monocarboxylic acid salt with potassium, strontium or barium, (2) a hydroxy-higher fatty acid salt with potassium, strontium or barium, (3) an aliphatic polycarboxylic acid salt with lithium, sodium, potassium, strontium or barium, (4) a salt of an aliphatic hydroxy acid having form 2 to 6 carbon atoms with lithium, sodium, potassium, magnesium, strontium or barium, (5) an aromatic carboxylic acid salt with lithium, sodium, strontium, barium or aluminum, (6) a glutamic acid salt with lithium, sodium, potassium, strontium or barium, (7) an aliphatic phosphoric acid salt with sodium, potassium, calcium, strontium or barium, (8) a lithium, sodium, potassium or barium salt of a cyclic phosphorus compound represented by formula (II): wherein Ar3 and Ar4, which may be the same or different, each represents an arylene group, an alkylarylene group, a cycloalkylarylene group, an arylarylene group or an aralkylarylene group; M represents lithium, sodium, potassium or barium; and m represents an atomic valence of M, (9) magnesium or aluminum hydroxide, (10) magnesium oxide, (11) magnesium or calcium carbonate and (12) hydrotalcite, and (C) from 0.01 to 1 part by weight of an aliphatic amine.

  本发明公开了一种结晶聚烯烃组合物，该组合物可提供具有改进的刚度特性的模塑制品，该组合物包括按重量计100份的结晶聚烯烃、(A)按重量计0.001至1份的由式(I)代表的亚磷酸氟化合物： 其中 R 代表具有 1 至 4 个碳原子的亚烷基或硫原子；Ar1 和 Ar2 可以相同或不同，各自代表烷基芳基或环烷基芳基；n 代表 0 或 1，以及 (B) 0.(1) 锂或钠的脂肪族一羧酸盐，(2) 锂、钠或钾的二硫代氨基甲酸盐、(3) 锂、钠或钾的 2-巯基苯并噻唑盐， (4) 锂、钠或钾的 2-巯基苯并咪唑盐， (5) 锂、钠或钾的苯并三唑盐。 本发明还公开了一种结晶聚烯烃组合物，该组合物可提供具有改进的刚度特性的模塑制品，其成分包括 100 份（重量）结晶聚烯烃、(A) 0.001 至 1 份（重量）由上文式(I)代表的亚磷酸氟化合物、(B ) 0.(1)钾、锶或钡的脂肪族一羧酸盐；(2)钾、锶或钡的羟基高级脂肪酸盐；(3)锂、钠、钾、锶或钡的脂肪族多羧酸盐；(4)锂、钠、钾、镁、锶或钡的具有 2 至 6 个碳原子的脂肪族羟基酸盐、(5) 锂、钠、锶、钡或铝的芳香族羧酸盐； (6) 锂、钠、钾、锶或钡的谷氨酸盐、(7) 含有钠、钾、钙、锶或钡的脂肪族磷酸盐， (8) 由式（II）代表的环磷化合物的锂、钠、钾或钡盐： 其中 Ar3 和 Ar4 可以相同或不同，各自代表芳基、烷芳基、环烷芳基、芳基芳基或芳基芳基；M 代表锂、钠、钾或钡；m 代表 M 的原子价，(9) 氢氧化镁或铝，(10) 氧化镁，(11) 碳酸镁或碳酸钙和 (12) 水滑石，以及 (C) 0.01至1份重量的脂肪族胺。